Medtide

Medtide Dividend

Dividend of Medtide (3880.HK) as of Nov 19, 2026.

Dividend

0.00CNY

Last updated:

How much dividend does Medtide 2026 pay?

According to the latest status from November 2026, Medtide paid a total of 0.00 CNY per share in dividends within the last 12 months. With the current Medtide price of 18.61 CNY, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical Medtide Dividends

Historical Medtide Dividends
PaydateDividend

The Medtide Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2021
0.00 CNY
Jan 1, 2022
0.00 CNY
Jan 1, 2023
0.00 CNY
Jan 1, 2024
0.00 CNY
Jan 1, 2025
0.00 CNY
Jan 1, 2026 (e)
0.00 CNY
Jan 1, 2027 (e)
0.00 CNY
The Medtide Dividend history
YEARDividendYoY
est0.00CNY—
est0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—

Is the Medtide Dividend Safe?

Medtide has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding Medtide's Dividend Distributions

Medtide’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Medtide's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Medtide's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Medtide’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Medtide Stock analysis

What does Medtide do? Medtide, Inc. generates revenue through peptide-focused contract research, development, and manufacturing services. The company offers CRO services for peptide new chemical entity (NCE) discovery and synthesis, alongside CDMO services covering peptide chemistry, manufacturing, and control (CMC) development and commercial production. Its primary clients are pharmaceutical companies seeking active pharmaceutical ingredients (APIs) rather than finished drug products, with services delivered across domestic and overseas markets. The firm's revenue streams are derived from these specialized peptide-related R&D and manufacturing contracts. Medtide's business model centers on providing comprehensive peptide development and manufacturing solutions, including CMC filing support for clients. The company's services target the API segment of the pharmaceutical industry, focusing on peptide-based drug development rather than final drug formulations. This specialization allows Medtide to serve clients requiring high-quality peptide synthesis and manufacturing capabilities for their drug development pipelines. The company's revenue is generated through direct contracts with pharmaceutical firms for peptide-related services, including discovery synthesis, CMC development, and commercial manufacturing. These services are delivered to clients operating in both domestic and international markets, with the firm emphasizing its expertise in peptide chemistry and manufacturing processes. Medtide's business model relies on its ability to provide end-to-end peptide development and manufacturing solutions to pharmaceutical clients. Medtide is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medtide stock

Medtide paid dividends every year for the past 0 years.

Medtide is assigned to the 'Health' sector.

The dividends of Medtide are distributed in CNY.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — Medtide